Tenax Therapeutics (TENX) Analyst & Key Data

Analyst Consensus

Buy9 analysts

Buy

Updated Sep 12, 2026

Total Analysts9

Buy

5

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.86

DCF Value+26.17%

$2.35

Potential upside vs current price

Current Stock Price

$1.86

DCF Value+26.17%

$2.35

Potential upside vs current price

Analyst Consensus

Buy9 analysts

Buy

Updated Sep 12, 2026

Total Analysts9

Buy

5

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.86

DCF Value+26.17%

$2.35

Potential upside vs current price

Current Stock Price

$1.86

DCF Value+26.17%

$2.35

Potential upside vs current price

Tenax Therapeutics, Inc.